MedPage Today - "Prostate Cancer: Genes Predict Survival"
Two different genetic signatures may offer some clue about prognosis in castration-resistant prostate cancer. In one study, a six-gene panel distinguished between patients with longer and shorter survival rates, according to William Oh, MD, of Mount Sinai School of Medicine in New York, and colleagues. They used blood samples from 62 men with castration-resistant prostate cancer and derived a six-gene panel that separated patients in two groups: one low-risk group with a median survival of more than 34.9 months and a high-risk group with a median survival of 7.8 months. Learn more